Skip to main content

Overview

This study is about people’s experiences using benzodiazepines that are not prescribed, including those obtained through street-based or online markets.

We want to learn more about:

  1. How people view the benefits, risks, and harms of using these benzodiazepines, including any good or bad effects they have experienced
  2. The practices and strategies people use in relation to benzodiazepines, such as sharing knowledge, looking after themselves, sourcing these drugs, and reducing harm

The information collected in this study will be reviewed by the research team to identify priority areas for community education, where harm reduction efforts should be directed, and the service needs of people who use benzodiazepines obtained from street or online markets. Findings will also help inform health promotion resources, clinical training, and harm reduction strategies.

 

What the Study Involves

If you agree to take part, you will first be asked to:

  • Read the Participant Information Sheet,
  • Provide your consent, and
  • Complete a short online survey

The survey will ask questions about you, such as your age, location, and experiences with benzodiazepines. Based on survey responses, some participants will then be invited to take part in a confidential interview.

  • Interviews may be conducted online or in person.
  • Each interview will last between 60 and 90 minutes.
  • Participants who complete an interview will receive a $60 for their time

Not everyone who completes the survey will be invited to an interview. This is because the study uses a quota sampling approach to include a diverse range of people based on age, location, and patterns of use.

 

Who Can Take Part?

You may be eligible if you:

  • Are aged 18 or older,
  • Live in Australia,
  • Have used benzodiazepines from unregulated sources (e.g. dealer or online market) on three or more occasions in the past 12 months,
  • Can speak and understand English, and
  • Agree to have the interview audio-recorded (if invited to participate).

 

How to Participate

  1. Read the Participant Information Sheet and Consent form.
  2. Provide consent to participate (you can provide your consent online).
  3. Complete the short screening survey.
  4. Based on your responses, you may then be invited to take part in an interview.

Investigators

Dr. Jack Freestone 

National Centre for Clinical Research on Emerging Drugs, UNSW  

Ms. Jess Doumany 

Australian Injecting and Illicit Drug Users League

Mr. John Gobeil 

Australian Injecting and Illicit Drug Users League    

Ms. Harriet MacDonald

National Centre for Clinical Research on Emerging Drugs, UNSW

Dr. Brendan Clifford 

National Centre for Clinical Research on Emerging Drugs, UNSW 

Dr. Krista Siefried 

National Centre for Clinical Research on Emerging Drugs, UNSW

Professor Nadine Ezard 

National Centre for Clinical Research on Emerging Drugs, UNSW

Dr. Cilla Zhou 

National Centre for Clinical Research on Emerging Drugs, UNSW

Mr. Stassi Kyrpi 

National Centre for Clinical Research on Emerging Drugs, UNSW

Mr.  Mitchel Lamb

Canberra Alliance for Harm Minimisation and Advocacy

Mr. Nick Kent 

Harm Reduction Victoria  

Ms. Isabelle Volpe 

Mr. Simon Caldwell 

National Centre for Clinical Research on Emerging Drugs, UNSW

In collaboration with

AIVL (Australian Injecting & Illicit Drug Users League) & CAHMA (Canberra Alliance for Harm Minimisation & Advocacy) and Harm Reduction Victoria